Home » ChromaDex, Scripps Reach Deal to Generate Tandem Mass Spec Data for Metabolite Database

ChromaDex, Scripps Reach Deal to Generate Tandem Mass Spec Data for Metabolite Database

May 31, 2012
|
staff reporter

NEW YORK (GenomeWeb News) – Natural products firm ChromaDex and the Scripps Center for Metabolomics have formed a partnership to generate tandem mass spectrometry data for compounds for inclusion in a metabolite database

Data from compounds from ChromaDex's products and phytochemical catalog will be included in the Scripps Metlin Metabolite Database, which contains metabolite information, such as tandem mass spectrometry information, for more than 55,000 potentially therapeutic compounds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Jul
19
Featured Webinar

Advances in NGS for Ultra-High Sensitivity Applications in Translational and Clinical Research

Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research. 

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.